Proposed Reimbursement changes for ESAs Another Setback for Amgen (AMGN) - Goldman Sachs
Go back to Proposed Reimbursement changes for ESAs Another Setback for Amgen (AMGN) - Goldman Sachs| Amgen Inc (NASDAQ: AMGN) | Delayed: 439.33 +5.60 (1.29%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $433.73 | 52 Week High | $176.85 | |||
| Open | $431.72 | 52 Week Low | $133.64 | |||
| Day High | $440.51 | P/E | 66.16 | |||
| Day Low | $429.38 | EPS | $6.64 | |||
| Volume | 2,114,678 | |||||
| DaVita Inc. (NYSE: DVA) | Delayed: 173.82 -1.42 (0.81%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $175.24 | 52 Week High | $78.77 | |||
| Open | $175.25 | 52 Week Low | $55.00 | |||
| Day High | $176.19 | P/E | 60.15 | |||
| Day Low | $173.74 | EPS | $2.89 | |||
| Volume | 633,631 | |||||
